​

Vir Bio (VIR) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Vir Bio Revenue Highlights

Latest Revenue (Y)

$74.20M

Latest Revenue (Q)

$240.00K

Main Segment (Y)

Contract Revenue

Main Geography (Y)

Non-US

Vir Bio Revenue by Period

Vir Bio Revenue by Year

DateRevenueChange
2024-12-31$74.20M-13.90%
2023-12-31$86.18M-94.55%
2022-12-31$1.58B45.39%
2021-12-31$1.09B1516.58%
2020-12-31$67.25M9357.81%
2019-12-31$711.00K-18.09%
2018-12-31$868.00K482.55%
2017-12-31$149.00K-

Vir Bio generated $74.20M in revenue during NA 2024, up -13.90% compared to the previous quarter, and up 10436.71% compared to the same period a year ago.

Vir Bio Revenue by Quarter

DateRevenueChange
2025-09-30$240.00K-80.23%
2025-06-30$1.21M-32.33%
2025-03-31$1.79M-84.09%
2024-12-31$11.28M373.87%
2024-09-30$2.38M-22.60%
2024-06-30$3.08M-94.55%
2024-03-31$56.38M235.83%
2023-12-31$16.79M536.11%
2023-09-30$2.64M-30.50%
2023-06-30$3.80M-91.87%
2023-03-31$46.71M114.38%
2022-12-31$21.79M-94.13%
2022-09-30$371.43M-1014.20%
2022-06-30$-40.63M-103.30%
2022-03-31$1.23B51.89%
2021-12-31$809.76M688.37%
2021-09-30$102.71M-40.96%
2021-06-30$173.99M28658.02%
2021-03-31$605.00K101.00%
2020-12-31$301.00K60.11%
2020-09-30$188.00K-99.72%
2020-06-30$66.27M13507.60%
2020-03-31$487.00K31.27%
2019-12-31$371.00K56.54%
2019-09-30$237.00K175.58%
2019-06-30$86.00K405.88%
2019-03-31$17.00K183.33%
2018-12-31$6.00K-94.74%
2018-09-30$114.00K-95.10%
2018-06-30$2.33M-
2018-03-31$2.33M-

Vir Bio generated $240.00K in revenue during Q3 2025, up -80.23% compared to the previous quarter, and up 7.80% compared to the same period a year ago.

Vir Bio Revenue Breakdown

Vir Bio Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21Dec 20
Collaboration Revenue$8.38M$37.27M$1.51B$917.19M-
Contract Revenue$55.33M$2.23M$52.71M$169.87M-
Grant$10.49M$46.69M---
License Revenue-----
License--$22.29M-$22.75M

Vir Bio's latest annual revenue breakdown by segment (product or service), as of Dec 24: Contract Revenue (74.57%), Grant (14.14%), and Collaboration Revenue (11.29%).

Quarterly Revenue by Product

Product/ServiceSep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20
Grant$305.00K$183.00K$1.24M$1.10M$2.09M$2.13M$5.17M$23.43M$6.74M$16.52M----------
Collaboration Revenue$-65.00K$-495.00K$-70.00K$8.32M$55.00K-$-4.39M$46.57M$21.61M$309.14M$-54.94M$1.23B$809.46M$102.40M$5.33M-----
Contract Revenue-$1.53M$1.86M$865.00K$1.39M$886.00K$52.19M$744.00K$289.00K$1.06M$138.00K$180.00K$40.00M$12.25M$282.00K$293.00K$315.00K$605.00K--
License Revenue--------------------
License------------$22.29M-------

Vir Bio's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Grant (127.08%), and Collaboration Revenue (-27.08%).

Vir Bio Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24
Non-US$60.31M
UNITED STATES$11.53M

Vir Bio's latest annual revenue breakdown by geography, as of Dec 24: Non-US (83.96%), and UNITED STATES (16.04%).

Quarterly Revenue by Country

CountrySep 25Jun 25Mar 25
UNITED STATES$305.00K$183.00K$1.24M
Non-US$-65.00K$1.53M$1.86M

Vir Bio's latest quarterly revenue breakdown by geography, as of Sep 25: UNITED STATES (127.08%), and Non-US (-27.08%).

Vir Bio Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MRVIMaravai LifeSciences$259.19M$41.63M
DNAGinkgo Bioworks$227.04M$49.60M
IOVAIovance Biotherapeutics$164.07M$67.45M
DAWNDay One Biopharmaceuticals$131.16M$39.80M
GERNGeron$76.50M$47.23M
VIRVir Bio$74.20M$240.00K
KURAKura Oncology$53.88M$20.75M
PRMEPrime Medicine$2.98M$1.23M
YDESYD Bio Limited Ordinary Shares$510.36K-
LENZLENZ Therapeutics-$5.00M
REPLReplimune Group--

VIR Revenue FAQ

What is Vir Bio’s yearly revenue?

Vir Bio's yearly revenue for 2024 was $74.2M, representing a decrease of -13.90% compared to 2023. The company's yearly revenue for 2023 was $86.18M, representing a decrease of -94.55% compared to 2022. VIR's yearly revenue for 2022 was $1.58B, representing an increase of 45.39% compared to 2021.

What is Vir Bio’s quarterly revenue?

Vir Bio's quarterly revenue for Q3 2025 was $240K, a -80.23% decrease from the previous quarter (Q2 2025), and a -89.92% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $1.21M, a -32.33% decrease from the previous quarter (Q1 2025), and a -60.52% decrease year-over-year (Q2 2024). VIR's quarterly revenue for Q1 2025 was $1.79M, a -84.09% decrease from the previous quarter (Q4 2024), and a -96.82% decrease year-over-year (Q1 2024).

What is Vir Bio’s revenue growth rate?

Vir Bio's revenue growth rate for the last 3 years (2022-2024) was -95.30%, and for the last 5 years (2020-2024) was 10.35%.

What are Vir Bio’s revenue streams?

Vir Bio's revenue streams in c 24 are Collaboration Revenue, Contract Revenue, and Grant. Collaboration Revenue generated $8.38M in revenue, accounting 11.29% of the company's total revenue, down -77.52% year-over-year. Contract Revenue generated $55.33M in revenue, accounting 74.57% of the company's total revenue, up 2383.53% year-over-year. Grant generated $10.49M in revenue, accounting 14.14% of the company's total revenue, down -77.52% year-over-year.

What is Vir Bio’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Vir Bio was Contract Revenue. This segment made a revenue of $55.33M, representing 74.57% of the company's total revenue.